SCHEMBL22947482

SCHEMBL22947482

Cc1ccc(S2(c3ccc(C)cc3)c3ccccc3-c3ccc(-c4ccccc4Cl)cc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS2 Q9H2K2 1/20 0.38
TRPA1 O75762 1/20 0.38
CYP2A6 P11509 1/20 0.37
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
TYK2 P29597 1/20 0.37
JAK3 P52333 1/20 0.37
PDK2 Q15119 1/20 0.36
PGR P06401 2/20 0.36
MAOB P27338 2/20 0.36
BACE1 P56817 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HSD11B1 P28845 1/20 0.34
NPC1 O15118 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947689 0.88 CYP2A6 (0.46) TNKS2TRPA1CYP2A6JAK2JAK1
SCHEMBL22947628 0.86 PDK2 (0.36) PDK2MEN1KMT2ANPC1ALDH1A1
SCHEMBL22947622 0.82 BACE1 (0.40) TRPA1CYP2A6JAK2JAK1TYK2
SCHEMBL17451613 0.79 CA12 (0.41) MEN1KMT2ANPC1ALDH1A1TP53
SCHEMBL22949554 0.78 NPC1 (0.42) MEN1KMT2ANPC1ALDH1A1TP53
SCHEMBL22947629 0.77 ALDH1A1 (0.39) MAOBMEN1KMT2AALDH1A1MAPT
SCHEMBL22949608 0.77 NPC1 (0.41) MEN1KMT2ANPC1ALDH1A1TP53
SCHEMBL22947701 0.77 CYP2A6 (0.45) TNKS2TRPA1CYP2A6JAK2JAK1
SCHEMBL22949019 0.77 KMT2A (0.34) CYP2A6MEN1KMT2AHSD11B1NPC1
SCHEMBL22947477 0.77 CYP2A6 (0.43) TNKS2TRPA1CYP2A6JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 TNKS2 4214/4885TRPA1 57/4885CYP2A6 1117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.